Cargando…
Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line
BACKGROUND: Angiogenesis is critical for the growth and metastasis of solid tumors and is, therefore, an important therapeutic target. Despite the great research advances in tumor therapies targeting vascular endothelial growth factor (VEGF), drug resistance frequently occurs, and further strategies...
Autores principales: | Xu, Xiaofeng, Yan, Yuhua, Xun, Qingying, Shi, Jiayu, Kong, Xiangyi, Wu, Jun, Zhou, Huaijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6388957/ https://www.ncbi.nlm.nih.gov/pubmed/30863089 http://dx.doi.org/10.2147/OTT.S194064 |
Ejemplares similares
-
Treatment with Tie2-siRNA in combination with carboplatin suppresses the growth of Ishikawa human endometrial carcinoma cell xenografts in vivo
por: GUO, FEIFEI, et al.
Publicado: (2013) -
Estrogen Regulates the Tumour Suppressor MiRNA-30c and Its Target Gene, MTA-1, in Endometrial Cancer
por: Kong, Xiangyi, et al.
Publicado: (2014) -
Partial silencing of fucosyltransferase 8 gene expression inhibits proliferation of Ishikawa cells, a cell line of endometrial cancer
por: Shimoyama, Hana, et al.
Publicado: (2020) -
Expression of the VEGF and angiopoietin genes in endometrial atypical hyperplasia and endometrial cancer
por: Holland, C M, et al.
Publicado: (2003) -
Biological activity of the receptor for macrophage colony-stimulating factor in the human endometrial cancer cell line, Ishikawa.
por: Takeda, S., et al.
Publicado: (1996)